Mohammad Isreb
RanTx
Dr. Mohammad Isreb is an accomplished academic and researcher with over 25 years of experience in the pharmaceutical sciences. He currently serves as an Associate Professor in the School of Pharmacy, Optometry and Medical Sciences at the University of Bradford, where he plays a pivotal role in advancing research and education in medicine development and pharmaceutical sciences.
Mohammad’s academic journey began at the University of Petra in Amman, Jordan, where he earned his undergraduate degree in Pharmacy and Medical Sciences in 2004. Following his graduation, he gained valuable hands-on experience in the pharmaceutical industry and healthcare sector.
His commitment to academic excellence led him to pursue postgraduate research at the University of Bradford’s School of Pharmacy from 2007 to 2011. This period marked the beginning of his long-standing association with the University of Bradford, where he has since built an impressive career.
About the Enterprise
Breast cancer affects 2.3 million women globally each year, and UK cases have risen by 24% since 1993. Current therapies, including chemotherapy and monoclonal antibodies, are costly, toxic, and often ineffective against chemoresistant cancers. Treating advanced breast cancer costs £75,000–£225,000 per patient annually, creating a significant financial and clinical burden.
The global oncology market is projected to surpass $300 billion by 2030, with precision medicine driving growth. RanTx offers a unique dual solution: a companion diagnostic test and a novel therapeutic peptide, addressing two high-value segments—diagnostics and targeted therapy—while offering affordability and scalability compared to monoclonal antibodies.
Mohammad and the RanTx® team aim to make RanTx a global standard for cancer care. RanTx promises to improve survival, reduce costs, and redefine cancer treatment worldwide.
Achievements
& Highlights
-
Received multiple Research Council grants to progress this research.
​
-
InnovateUK grant to commercialise the diagnostic side.
​
-
Total grants earned across RanTx® are more than £2.3m
Contact
Got an idea, question, or collaboration in mind? Let’s connect.
